Beta-adrenergic regulation of adenylyl cyclase signaling system in the myocardium and brain of rats with obesity and type 2 diabetes mellitus as affected by long-term intranasal insulin administration

被引:0
作者
L. A. Kuznetsova
T. S. Sharova
M. N. Pertseva
A. O. Shpakov
机构
[1] Russian Academy of Sciences,Sechenov Instititue of Evolutionary Physiology and Biochemistry
来源
Journal of Evolutionary Biochemistry and Physiology | 2015年 / 51卷
关键词
adenylyl cyclase; norepinephrine; isoproterenol; β3-adrenergic receptor agonists; obesity; type 2 diabetes mellitus; insulin;
D O I
暂无
中图分类号
学科分类号
摘要
The stimulatory effects of norepinephrine, isoproterenol and selective ß3-adrenoceptor agonists BRL 37344 and CL 316.243 on the adenylyl cyclase signaling system (ACSS) in the brain and myocardium of young and mature rats with experimental obesity and type 2 diabetes mellitus (DM2) (disease induction at 2 and 4 months of age, respectively) and the influence of the long-term intranasal insulin (I-I) administration were studied. It was shown that the AC-stimulatory effects of ß-agonist isoproterenol in animals with obesity and DM2 practically did not change. The respective effects of norepinephrine on the AC activity slackened in the brain of young and mature rats and myocardium of mature rats, while the I-I treatment led to their partial recovery. In the brain and myocardium of mature rats with obesity and DM2 an increase in the AC-stimulatory effects of ß3- AR agonists was observed, while in young rats the similar influence of the same pathologies was mißsing. The I-I treatment resulted in an attenuation of the AC-stimulatory effects of ß3-agonists to their control level. Since the disruption of the adrenergic agonist-sensitive ACSS is one of the causes of metabolic syndrome and DM2, the recovery of ACSS dysfunctions by the long-term I-I administration offers one of the ways of correcting these diseases and their complications in the nervous and cardiovascular systems.
引用
收藏
页码:198 / 209
页数:11
相关论文
共 183 条
  • [1] Dinçer U.D.(2001)The effect of diabetes on expression of beta1-, beta2-, and be-ta3-adrenoreceptors in rat hearts Diabetes 50 455-461
  • [2] Bidasee K.R.(2001)erial changes in the myocardial beta-adrenergic signalling system in two models of noninsulin dependent diabetes mellitus Mol. Cell. Biochem. 219 73-82
  • [3] Güner S.(2004)Structure and function of beta3-adrenergic receptors Medicina (Kaunas) 40 407-413
  • [4] Tay A.(2012)Alterations in hormonal signaling systems in diabetes mellitus: origin, causality and specificity Endocrinology & Metabolic Syndrome 1 106-108
  • [5] Ozçelikay A.T.(1998)Site-directed mutagenesis of the human beta3- adrenoceptor-transmembrane residues involved in ligand binding and signal transduction Eur. J. Biochem. 251 590-596
  • [6] Altan V.M.(2006)Differential coupling of ß3A- and ß3B-adrenergic receptors to endogenous and chimeric Gα Am. J. Physiol. Endocrinol. Metab. 291 E704-E715
  • [7] Huisamen B.(2002) and Gα Biochem. Biophys. Res. Commun. 298 824-828
  • [8] Marais E.(2004)Efficient adenylyl cyclase activation by a ß2-adrenoreceptor-G Cell Signal. 16 1397-1403
  • [9] Genade S.(2010)α Brain Res. Bull. 81 605-612
  • [10] Lochner A. S.(2005) fusion protein Am. J. Physiol. 289 2234-2243